FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Antibiotic topics
Antibiotic
Antibiotics
Daptomycin
Antibacterial
Amino Acid
Bacterial Infection
Bacterial Infections
Recombinant
Acne Vulgaris
Vancomycin
Acne Treatment
Chromatograph
Chromatography
Streptomyces
Therapeutical

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Antibiotic patents



      
           
This page is updated frequently with new Antibiotic-related patent applications. Subscribe to the Antibiotic RSS feed to automatically get the update: related Antibiotic RSS feeds. RSS updates for this page: Antibiotic RSS RSS


Date/App# patent app List of recent Antibiotic-related patents
07/24/14
20140206659
 Tazobactam arginine antibiotic compositions patent thumbnailnew patent Tazobactam arginine antibiotic compositions
This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.. .
07/24/14
20140206573
 Method for evaluating bacterial cell wall integrity patent thumbnailnew patent Method for evaluating bacterial cell wall integrity
The present invention relates to a method for evaluating the integrity of the cell wall of the bacteria present in a culture in the presence of an antibiotic acting on the bacterial cell wall which, from a practical point of view, allows quickly determining if a bacterium is sensitive or resistant to an antibiotic acting on the bacterial cell wall. Likewise, the present invention also relates to a lysis solution applicable in the preceding method, specifically affecting bacteria having the cell wall damaged by the action of an antibiotic acting on the bacterial cell wall, which allows distinguishing bacteria sensitive to said antibiotic from those resistant to said antibiotic..
07/17/14
20140200197
 Hiv protease inhibitors patent thumbnailHiv protease inhibitors
The compounds encompassed by formula i include compounds which are hiv protease inhibitors and other compounds which can be metabolized in vivo to hiv protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by hiv and the prophylaxis, treatment, or delay in the onset of aids.
07/17/14
20140200193
 Thixotropic biological adhesive for use in internal body cavities patent thumbnailThixotropic biological adhesive for use in internal body cavities
A biological thixotropic adhesive that contains dextrin, and at least a structural component that provides thixotropy to the adhesive, and optionally at least an antibiotic that is very useful to stimulate the process of healing of tissues in a patient, for example, to prevent anastomotic leaks of the gastrointestinal system, to affix a prosthesis in inguinal hernioplasties, in a patient and to oclude a fistula in a patient. The biological thixotropic dahesive also has anti-inflammatory properties and can be used with a fatty tissue patch..
07/17/14
20140199375
 Combination therapy for skin disorders patent thumbnailCombination therapy for skin disorders
The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.. .
07/17/14
20140199289
 Use of matrix metalloproteinase inhibitors to treat tuberculosis patent thumbnailUse of matrix metalloproteinase inhibitors to treat tuberculosis
The present invention provides a method for treating a subject suffering from tuberculosis which comprises administering to the subject a composition comprising an amount of an inhibitor of a matrix metalloproteinase (mmp) in an amount effective to treat the subject, such that the therapeutic effect of said composition is different than the therapeutic effect attributable to the antibiotic properties of said composition. The present invention also provides a method for reducing or inhibiting destruction of lung extracellular matrix in a subject comprising administering to the subject at risk for such destruction a composition comprising an amount of an inhibitor of a matrix metalloproteinase (mmp) in an amount effective to reduce or inhibit destruction of lung extracellular matrix in the subject..
07/10/14
20140194375
 Topical antibiotic composition for the prevention of lyme disease patent thumbnailTopical antibiotic composition for the prevention of lyme disease
The invention relates to topical pharmaceutical compositions and methods related to borrelia burgdorferi toxins, in particular, the present invention provides compositions and methods for the treatment of infections caused by borrelia burgdorferi and in particular for the prevention of lyme disease.. .
07/10/14
20140193530
 Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug patent thumbnailPharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug
Provided is a pharmaceutical composition useful for prevention and/or treatment of diseases caused by bacteria, wherein the pharmaceutical composition comprising a honeysuckle extract containing iridoid compounds and an antibiotic. Also provided is a pharmaceutical kit comprising the honeysuckle extract containing the iridoid compounds and the antibiotics which are separately placed.
07/10/14
20140193372
 Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities patent thumbnailReducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
The present invention provides for microbial compositions and methods for reducing the concentration of short-chain fatty acids in the gut as a way to reduce energy uptake and manage obesity. More specifically, the invention provides for decreasing short-chain fatty acids available for absorption in the human gut, such as acetate, using one or more of: a probiotic including a homo-acetogenic, acetate oxidizing bacterium that converts acetate to h2; a probiotic including an acetoclastic methanogen; a microbial electrolysis cell comprising a homo-acetogenic bacterium and/or an acetoclastic methanogen; a prebiotic that enhances the growth or function of acetate-scavenging microbiota; or a highly selective antibiotic that targets h2-oxidizing methanogens..
07/03/14
20140188033
 Drug delivery using a sacrificial host patent thumbnailDrug delivery using a sacrificial host
Implantable drug-doped component, e.g., a cochlear implant, including host material, a host-embedded drug, a sacrificial material integrated with the host. Sacrificial material facilitates release of drug from the component.
07/03/14
20140187780
6,11-bridged biaryl macrolides
Which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment.
07/03/14
20140187528
Tazobactam arginine antibiotic compositions
This disclosure provides compositions comprising a beta-lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.. .
07/03/14
20140187512
Use of lactulose in the treatment of autism
A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria.
07/03/14
20140187475
Lantibiotic compositions and methods for preventing or treating mastitis
A composition suitable for application to the skin comprising at least one lantibiotic, an acidic external phase aqueous solution, at least one pharmaceutically acceptable internal phase carrier material, and a combination thereof. A method for preventing or treating mastitis, comprising administering to a human in need of such treatment a topical composition comprising a therapeutically-effective amount of at least one lantibiotic, an acidic aqueous solution, and at least one pharmaceutically acceptable carrier material..
07/03/14
20140187446
Affinity-based detection of biological targets
A method of biochemical identification by: providing a plurality of capture species bound to one or more substrates and suspected of having one or more biological targets affinity bound to at least one capture species; detecting which capture species contain bound biological targets to generate a binding pattern; and identifying the biological target based on the binding pattern. The capture species are independently selected from the group consisting of antimicrobial peptides, cytotoxic peptides, antibiotics, and combinations thereof.
07/03/14
20140187443
Antibacterial and plasmid elimination agents
Inhibitors of the tmrna pathway have antibacterial activity with broad species specificity, including b. Anthracis and other pathogens of military and civilian interest.
07/03/14
20140186873
Synthesis and use of isotopically labeled macrocyclic compounds
Disclosed herein are isotopically labeled antifungal antibiotics and related compounds. Also disclosed are methods for synthesizing these isotopically labeled molecules and using the same to study the distribution of these compounds in the biosphere as well as the products formed by the breakdown of these isotopically labeled compounds..
07/03/14
20140186269
Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active agents for the treatment of human skin, especially in the treatment of acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, p. Acne bacteria associated disorders, and other superficial infections, including skin infections..
06/26/14
20140179929
Synthesis of enone intermediate
The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics.
06/26/14
20140179691
Novel oxazolidinone derivative and medical composition containing same
The novel oxazolidinone derivative, the prodrug thereof, the hydrate thereof, the solvate thereof, the isomer thereof, and the pharmaceutically acceptable salt thereof have broad antibacterial spectrum against resistant bacteria, low toxicity and strong antibacterial effects against gram-positive and gram-negative bacteria and thus may be effectively used as antibiotics.. .
06/26/14
20140179594
Streptococcus bacteriophage lysins for treatment of gram positive bacteria in companion animals and livestock
The present invention provides methods for the prophylactic and therapeutic amelioration and treatment of gram-positive bacteria in companion animals and livestock, including streptococcus and staphylococcus bacterial strains, including pathogenic and antibiotic-resistant bacteria, and related conditions. The methods of the invention utilize plyss2 and/or plyss1 lytic enzymes and variants thereof, including truncations thereof.
06/26/14
20140178971
Toxin-eating bacteria and bioremediation
Bacteria that can use antibiotics as a carbon source are provided. Methods and bacteria useful for bioremediation are also provided..
06/26/14
20140178342
Method for treating infectious skin diseases using live penicillium notatum fungus
The invention relates to a method for treating skin diseases using live “penicillium notatum” fungus. There is still little known about the “penicillium notatum” fungus.
06/19/14
20140172448
Method for measuring the incidence of hospital acquired infections
Disclosed is a method and system for analyzing patient hospitalization data to determine a nosocomial infection marker (nim), the method comprising receiving from a database hospitalization data associated with at least one patient, calculating from the hospitalization data the number of specimens with non-duplicate hospital isolates (sndhi) markers, calculating from the hospitalization data antibiotic utilization criteria (auc) markers, and determining the nosocomial infection marker (nim) for each patient, based upon the calculated. Sndhi and auc markers..
06/19/14
20140171445
Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance
The invention provides a method of enhancing the efficacy of antibiotic treatment of tuberculosis, trypanosomiasis, leprosy, and leishmaniasis involving co-administering to a mammal undergoing antibiotic treatment therapeutically effective amounts of a first compound that is an inhibitor of 5-lipoxygenase and optionally a second compound that is a product of the cyclooxygenase pathways. The invention also provides a pharmaceutical composition comprising an antibiotic, an inhibitor of 5-lipoxygenase, and a product of the cyclooxygenase pathways..
06/19/14
20140171359
Diagnosis of respiratory tract infectious diseases using urine specimens
Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for determining the timing for ending administration of an antibiotic to a patient with respiratory infection receiving the antibiotic, wherein said methods are characterized in that they are able to appropriately select patients with respiratory infection to whom the antibiotic is to be administered, to adjust the administration period of the antibiotic, and to treat respiratory infection associated with bacterial infection, and in that a measured value of scd14-st in urine is used as an indication.. .
06/19/14
20140171358
Antimicrobial compositions comprising dgla and neomycin sulfate and methods of use thereof
The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., c1-c4 esters) including, for example, dgla, 15-ohepa and/or 15-hetre, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing.. .
06/19/14
20140171350
Cleaner
A composition for cleaning and sanitizing dental appliances and dentures having at least one of anti-viral, anti-fungal, antibacterial, germicidal, and anti-microbial properties and comprising (a) a surfactant system having a quaternary amine as a first component and a nonionic surfactant as a second component, (b) peppermint oil, (c) a quaternary salt additive, (d) propolis resin extract, (e) antibiotic additive, and (f) triclosan.. .
06/19/14
20140170207
Antimicrobial compounds and methods of use
The present disclosure provides antimicrobial compounds, compositions comprising such antimicrobial compounds, and methods of their use, in particular, antibacterial compounds and antifungal compounds. In certain aspects, the antimicrobial compounds are effective against pathogens of hospital-acquired infections.
06/19/14
20140170125
Use of cardiotrophin-1 for the treatment of kidney diseases
The present invention relates to the use of cardiotrophin-1 (ct-1) for the prevention and/or treatment of acute renal injury, specially of acute kidney injury induced by nephrotoxic agents, such as contrast agents, antibiotics, immunosuppressive agents or antineoplastic agents. The invention is also related to compositions comprising said nephrotoxic agents and cardiotrophin-1..
06/12/14
20140163238
Synthesis of tetracyclines and analogues thereof
The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics.
06/12/14
20140162937
Polymyxin derivatives and uses thereof
The present invention relates to a polymyxin derivative and to a combination product comprising at least two such derivatives. The invention further relates to a method for treating, alleviating or ameliorating an infection in a subject caused by a gram-negative bacterium, by administering a therapeutically effective amount of a derivative according to the present invention to said subject; to a method for sensitizing gram-negative bacteria to an antibacterial agent by administering, simultaneously or sequentially in any order a therapeutically effective amount of said antibacterial agent and a derivative according to the present invention to said subject; to methods for developing novel antibiotics; for reducing the nephrotoxicity, for improving the pharmacokinetic properties of natural polymyxins and octapeptins; and for sensitizing clinically important bacteria to a host defense mechanism complement present in serum.
06/12/14
20140162314
High-yield peptide antibiotics producing strain, preparation method and use thereof
High-yield antibiotics producing strain, preparation method and use thereof are provided in the present invention. The high-yield strain is a mutagenized strain derived from colephoma empetri, and deposited in cgmcc with the accession number of cgmcc 4129.
06/12/14
20140159282
Method and device for producing temporary knee joint spacers with stems of various sizes
A cement mold assembly configured to form a temporary implant for use in delivering antibiotics to an infected site can includes a first mold and a second mold. The first mold can have an open end and an inner wall.
06/05/14
20140154694
Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant staphylococcus aureus (mrsa) and other methicillin-resistant bacteria in a sample..
06/05/14
20140154339
Fast acting inhibitor of gastric acid secretion
The present invention relates to the use of pharmaceutically acceptable zinc salts, in particular, zinc chloride and zinc acetate, alone or optionally, in combinations with one or more of a protein pump inhibitor (ppi), h2 blocker, anti-h. Pylori antibiotic/antimicrobial, cytoprotective agent or a combination agent as otherwise described herein for providing fast action with optional long duration effect in reducing gastric acid secretion, including acid secretion in the fundus (by inhibiting vacuolar h+-atpase or h+/k+-atpase) and upper body region of the stomach (by inhibiting h+/k+-atpase), thus raising the ph of gastric juices in rapid fashion and decreasing the duration of stomach acid release during a secretagogue phase.
06/05/14
20140154317
Pharmaceutical composition for treatment of helicobacter pylori associated diseases
An oral pharmaceutical composition for the treatment of helicobacter pylori associated diseases is disclosed comprising a proton pump inhibitor, an antibiotic or a combination of antibiotics, and additionally at least one agent selected from the group consisting of a) taurolidine or taurultam or a combination thereof, b) a zinc amino acid chelate, c) tromethamole, within a fixed-dose combination for oral administration in the form of either an instant release formulation, for example a compressed tablet, granules or the like, or in the form of a biphasic release form, for example a tablet with a slow release core and a compressed outer fast release layer, wherein the tromethamole is always present in instant release formulations.. .
06/05/14
20140154236
Devices and methods for treating pain associated with tonsillectomies
Described here are devices and methods for treating one or more conditions or symptoms associated with a tonsil procedure. In some variations, a drug-releasing device may be at least partially delivered to one or more tonsillar tissues before, during, or after a tonsil procedure.
05/29/14
20140148595
Method for the preparation of carbapenam compounds
The subject of the present invention is a method of the preparation of compounds containing the core skeleton of carbapenem antibiotics, novel intermediate compounds used in this method, a method of the preparation of the intermediate compounds as well as the use of the intermediate compounds in the production of carbapenem antibiotics.. .
05/29/14
20140147467
Novel broth medium and blood free solid media
The present invention relates to new contamination resistant artificial media for the routine cultivation of p. Salmonis.
05/22/14
20140142144
Oxazolidinone compounds and their uses in preparation of antibiotics
The invention belongs to the field of medicaments, and particularly relates to oxazolidinone compounds and their uses in the preparation of antibiotics. A technical problem to be solved by the invention is to provide new oxazolidinone compounds having the structure represented by formula i.
05/22/14
20140142093
Tricyclic oxazolidinone antibiotic compounds
The present invention relates to antibacterial compounds of formula (i) wherein “----” is a bond or is absent, v is ch, cr6 or n; r0 is h or, if “----” is a bond, may also be alkoxy; r1 is cyano, alkyl, or ethynyl; u is ch or n when “----” is a bond, or, if “----” is absent, u is ch2, nh or nh9; r2 is h, alkylcarbonyl or ch2—r3; r3 is h, alkyl or hydroxyalkyl; r4 is h or, if n is not 0 and r5 is h, may also be oh; r5 is h, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; r6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(ch2)q—nr7r8, q being 1, 2 or 3 and each of r7 and r8 independently being h or alkyl or r7 and r8 forming with the n atom bearing them a ring; r9 is alkyl or hydroxyalkyl; a is —(ch2)p—, —ch2ch2ch(oh)— or —coch2ch(oh)—; g is substituted phenyl or g1 or g2, wherein q is o or s and x is ch or n; and y1, y2 and y3 may each be ch or n; and n is 0 when a is —ch2ch2ch(oh)— or —coch2ch(oh)—, and n is 0, 1 or 2 when a is —(ch2)p—, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.. .
05/22/14
20140142055
Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
A method of treating a recurring meibomian gland disorder in a patient includes administering to a patient suffering from recurring meibomian gland disorder a composition comprising a therapeutically effective amount of an azalide antibiotic and a glucocorticoid. The method may thereby reduce the frequency of recurrence of the meibomian gland disorder..
05/22/14
20140142029
Macrocyclic broad spectrum antibiotics
Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (spsb), an essential protein in bacteria.
05/22/14
20140141979
Method for identifying antibiotic targets
(c) comparing the distribution of tna insertions between test cultures to identify a putative essential gene serving as a target of said antibiotic in said bacterium.. .
05/15/14
20140135485
6-11 bicyclic ketolide derivatives
Which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment.
05/15/14
20140135234
Method for identifying antibiotic targets by complemented sequencing
(d) comparing the distribution of transposon insertions between test cultures to identify a putative essential gene serving as a target of said antibiotic in said bacterium.. .


Popular terms: [SEARCH]

Antibiotic topics: Antibiotic, Antibiotics, Daptomycin, Antibacterial, Amino Acid, Bacterial Infection, Bacterial Infections, Recombinant, Acne Vulgaris, Vancomycin, Acne Treatment, Chromatograph, Chromatography, Streptomyces, Therapeutical

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Antibiotic for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Antibiotic with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2385

3338

0 - 1 - 71